Clear Impact logo

Immunization Program

# of Influenza vaccines were given out monthly

Current Value

7

Feb 2024

Definition

Line Bar

Story Behind the Measure

What's Helping What We Do?

These are the positive forces at work in our strategy/ program that influence how much we do or how well we do it.

  •   Vaccines available for both private insurance carriers and medicaid recipients
  •    School events to administer vaccines
  •    Social media advertisement of when flu shots are available
  •    All nurses trained to administer vaccines to help speed up immunization appointments
  •    Educational material on Flu vaccine

What's Hurting What We Do?

These are the negative forces at work in our strategy/program that influence how much we do or how well we do it.

  •   Stagima surrounding Flu vaccine
  •   Waiting times for private and state vaccines to arrive at health department   
  •   Staffing retention issues

What Works to Do Better (Performance)?

The following actions have been identified by CHA Team as ideas for what can work for this performance measure to make a difference on Prevention and Management of Acute Respiratory Infections.

(A) Actions and Approaches Identified by Our CHA Team. These are actions and approaches that we think can make a difference for this performance measure.

  • Influenza, Pneumonia, and COVID-19 vaccines to help decrease the effects from these viruses
  • Monoclonal Antibody treatment
  • Early detection of an illness
  • Proper use of an incentive spirometer
  • Information/education on these infections

(B) No-cost and Low-cost Ideas Identified by Our CHA Team. These are no-cost and low-cost actions and approaches that we think can make a difference for this performance measure.

  • Providing education to individuals about signs of Respiratory Distress
  • Immunizations are covered by most insurance companies

(C) What your customers think would work to do better. These are actions and approaches that our customers think can make a difference for this performance measure.

  • Increase vaccinations
  • Monoclonal Antibodies

(D) List of Questions/Research Agenda These are questions to follow-up on for this performance measure. 

  • Did we see an improvement with Covid-19 patients after receiving Monoclonal Antibodies?
  • Does vaccines lessen the effects of these respiratory illnesses?
  • Does early detection make a difference with treatment?

Clear Impact Suite is an easy-to-use, web-based software platform that helps your staff collaborate with external stakeholders and community partners by utilizing the combination of data collection, performance reporting, and program planning.

Scorecard Container Measure Action Actual Value Target Value Tag S A m/d/yy m/d/yyyy